CureVac NV (CVAC)
3.91
+0.62
(+18.84%)
USD |
NASDAQ |
May 22, 16:00
3.95
+0.04
(+1.02%)
After-Hours: 20:00
CureVac Cash and Short Term Investments (Quarterly): 447.81M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 447.81M |
| September 30, 2023 | 494.95M |
| June 30, 2023 | 590.40M |
| March 31, 2023 | 676.71M |
| December 31, 2022 | 536.50M |
| September 30, 2022 | 534.17M |
| June 30, 2022 | 602.91M |
| March 31, 2022 | 739.84M |
| Date | Value |
|---|---|
| December 31, 2021 | 924.02M |
| September 30, 2021 | 1.240B |
| June 30, 2021 | 1.661B |
| December 31, 2020 | 1.630B |
| September 30, 2020 | 1.049B |
| March 31, 2020 | 49.51M |
| December 31, 2019 | 36.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
36.00M
Minimum
Dec 2019
1.661B
Maximum
Jun 2021
747.51M
Average
602.91M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Affimed NV | 80.58M |
| InflaRx NV | 90.62M |
| MorphoSys AG | 754.72M |
| BioNTech SE | 16.92B |
| Immatics NV | 609.01M |